These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1346404)

  • 21. Long-term adjuvant tamoxifen therapy for breast cancer: the prelude to prevention.
    Jordan VC
    Cancer Treat Rev; 1990 Mar; 17(1):15-36. PubMed ID: 2224868
    [No Abstract]   [Full Text] [Related]  

  • 22. A molecular strategy to control tamoxifen resistant breast cancer.
    Jiang SY; Jordan VC
    Cancer Surv; 1992; 14():55-70. PubMed ID: 1423331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Status of antiestrogen breast cancer prevention trials.
    Powles TJ
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):28-31. PubMed ID: 9556788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal systemic therapy for premenopausal women with hormone receptor-positive breast cancer.
    Jankowitz RC; McGuire KP; Davidson NE
    Breast; 2013 Aug; 22 Suppl 2():S165-70. PubMed ID: 24074781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aromatase inhibitors for the treatment and prevention of breast cancer.
    Kalidas M; Brown P
    Clin Breast Cancer; 2005 Apr; 6(1):27-37. PubMed ID: 15899070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tamoxifen for prevention of breast cancer.
    Cersosimo RJ
    Ann Pharmacother; 2003 Feb; 37(2):268-73. PubMed ID: 12549959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The tamoxifen controversy.
    Crabbe WW
    Oncol Nurs Forum; 1996 Jun; 23(5):761-6. PubMed ID: 8792346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Adjuvant therapy of breast cancer with tamoxifen and endometrial carcinoma].
    Mignotte H; Sasco AJ; Lasset C; Saez S; Rivoire M; Bobin JY
    Bull Cancer; 1992; 79(10):969-77. PubMed ID: 1292764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamoxifen in postmenopausal women a safety perspective.
    Robinson E; Kimmick GG; Muss HB
    Drugs Aging; 1996 May; 8(5):329-37. PubMed ID: 8935395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tamoxifen as adjuvant therapy in breast cancer. Current status.
    Plowman PN
    Drugs; 1993 Nov; 46(5):819-33. PubMed ID: 7507033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted antiestrogens for the prevention of breast cancer.
    Bentrem DJ; Jordan VC
    Oncol Res; 1999; 11(9):401-7. PubMed ID: 10821534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.
    Fisher B; Costantino JP; Wickerham DL; Cecchini RS; Cronin WM; Robidoux A; Bevers TB; Kavanah MT; Atkins JN; Margolese RG; Runowicz CD; James JM; Ford LG; Wolmark N
    J Natl Cancer Inst; 2005 Nov; 97(22):1652-62. PubMed ID: 16288118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemosuppression of breast cancer with tamoxifen: laboratory evidence and future clinical investigations.
    Jordan VC
    Cancer Invest; 1988; 6(5):589-95. PubMed ID: 3063338
    [No Abstract]   [Full Text] [Related]  

  • 36. National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention Trial.
    Giles K; Flynn PJ; Dalton R; Zera R
    Minn Med; 1993 Dec; 76(12):25-7. PubMed ID: 8127293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor response of breast cancer to tamoxifen.
    McDonald PJ; Carpenter R; Royle GT; Taylor I
    Postgrad Med J; 1990 Dec; 66(782):1029-31. PubMed ID: 2084647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    Jordan VC; Brodie AM
    Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A risk-benefit assessment of tamoxifen therapy.
    Catherino WH; Jordan VC
    Drug Saf; 1993 May; 8(5):381-97. PubMed ID: 8504018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tamoxifen adjuvant treatment duration in early breast cancer: initial results of a randomized study comparing short-term treatment with long-term treatment. Fédération Nationale des Centres de Lutte Contre le Cancer Breast Group.
    Delozier T; Spielmann M; Macé-Lesec'h J; Janvier M; Hill C; Asselain B; Julien JP; Weber B; Mauriac L; Petit JC; Kerbrat P; Malhaire JP; Vennin P; Leduc B; Namer M
    J Clin Oncol; 2000 Oct; 18(20):3507-12. PubMed ID: 11032592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.